Private Equity

US

VC-backed Akero Therapeutics debuts IPO

Akero Therapeutics Inc, a biotech firm, has raised about $92 million for its IPO after pricing its 5.75 million shares at $16 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "AKRO." J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group L.L.C. are the lead underwriters. Akero's pre-IPO investors included Janus Henderson Investors, Redmile Group, Boxer Capital of Tavistock Group, Cormorant Asset Management, BVF Partners, Rock Springs Capital, LifeSci Venture Partners, Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures.

3 min read · 20 June 2019

Prevail Therapeutics begins trading on NASDAQ

New York City-based Prevail Therapeutics, a gene therapy company, has gone public after pricing its over 7.3 million shares at $17 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "PRVL." Morgan Stanley, BofA Merrill Lynch and Cowen are the lead underwriters. Prevail’s pre-IPO backers included OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.

2 min read · 20 June 2019

VC-backed Personalis unveils IPO

Personalis Inc, a provider of advanced genomics solutions for cancer, has debuted its IPO after pricing its nearly 8 million shares at $17 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "PSNL." Morgan Stanley, BofA Merrill Lynch and Cowen are the lead underwriters. Personalis' pre-IPO backers included Lightspeed Venture Partners, Abingworth and Mohr Davidow Ventures.

2 min read · 20 June 2019

Comet Therapeutics picks up $28.5 mln Series A

Comet Therapeutics, a biotech firm, has raised $28.5 million in Series A funding. Canaan and Sofinnova Partners led the round.

1 min read · 20 June 2019

Partech leads Series B round for Bitrise

Bitrise, a mobile continuous integration and delivery platform, has secured $20 million in Series B funding. Partech led the round with participation from Zobito, OpenOcean, Y Combinator and Fiedler Capital. Partech’s Reza Malekzadeh and OpenOcean’s Ekaterina Almasque will join the company’s board.

1 min read · 20 June 2019

Rhumbix procures $14.3 mln Series B

San Francisco-based Rhumbix, a mobile platform for smarter construction sites, has secured $14.3 million in Series B funding. Blackhorn Ventures and Tenfore Holdings led the round with participation from Greylock Partners, S28 Capital, South Park Ventures and Glynn Capital.

1 min read · 20 June 2019

Chinese B2B auto parts trading platform Haoqipei inks $60 mln

China-based Haoqipei, a B2B auto parts trading platform, has secured $60 million in Series D funding. Access Technology Ventures led the round with participation from other investors that included XVC Venture Capital, Jeneration Capital, DCM and SIG.

3 min read · 20 June 2019

Dawn Capital collects $125 mln for fourth fund: Reuters

Dawn Capital, an early-stage venture firm, has raised $125 million for its fourth fund, according to Reuters. The Dawn Capital Opportunities Fund targets European B2B tech companies.

1 min read · 20 June 2019

Ockam nets $3.2 mln seed

Ockam, a severless platform for IoT developers, has raised $3.2 million in seed funding, according to a blog post on its site. The investors were Core Ventures, Future Ventures, Okta and SGH Capital.

1 min read · 20 June 2019

Engage3 pockets $12 mln Series C

Engage3, which helps retailers manage their price image through accurate competitive data, data science and AI-powered software solutions, has raised $12 million in Series C financing. The March Fund led the round.

1 min read · 20 June 2019

Showing 4,021 to 4,030 of 41,793 results
1…402404…1000